Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05366140 · ClinicalTrials.gov registry record

Thoracic-Lumbar Arthrodesis- Implanet Jazz

A clinical trial of Spondylolisthesis and Spinal Stenosis, sponsored by Francis Farhadi.

Recruiting
Registry status
300
Enrollment target
1
Study location

NCT05366140: Recruiting study of Spondylolisthesis and Spinal Stenosis, sponsored by Francis Farhadi.

NCT05366140 is a study of Spondylolisthesis and Spinal Stenosis that is actively recruiting participants, run by Francis Farhadi. The registered enrollment target is 300 participants, above the 136-participant average among 18 other Spondylolisthesis trials with a reported enrollment target (121% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05366140, a study of Spondylolisthesis and Spinal Stenosis, is actively recruiting participants, sponsored by Francis Farhadi.

RECRUITING
Registry status
300 participants
Enrollment target
1
Study location

Study Summary

Establish a data repository of patients who have undergone single, two-, or three-level lumbar instrumented arthrodesis procedures supplemented by the Implanet Jazz System.

Primary Outcome

Collecting clinical measurements. Examples of these clinical measurements are the VAS Pain Scale, SF-36, NDI, and ODI.

Interventions

  • OTHER Prospective follow-up of patients who have received instrumented lumbar arthrodesis supplemented the Implanet Jazz System(TM)

Study Locations (1)

Kentucky

  • University of Kentucky - Lexington

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2022-02-03
Est. Completion 2028-09
Francis Farhadi

8 total trials

What NCT05366140 shows while recruiting

NCT05366140 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 136-participant average among 18 other Spondylolisthesis trials with a reported enrollment target (121% higher).

The record links to 3 conditions, with Spondylolisthesis appearing as the primary indexed condition, and to 1 intervention - of which Prospective follow-up of patients who have received instrumented lumbar arthrodesis supplemented the Implanet Jazz System(TM) is the first listed.

NCT05366140 reports a single indexed study location in Kentucky.

Frequently Asked Questions

What is clinical trial NCT05366140 about?

NCT05366140 is a clinical study titled "Thoracic-Lumbar Arthrodesis- Implanet Jazz". Establish a data repository of patients who have undergone single, two-, or three-level lumbar instrumented arthrodesis procedures supplemented by the Implanet Jazz System.

What is the current status of trial NCT05366140?

This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2022-02-03. Estimated completion is 2028-09.

What conditions does trial NCT05366140 study?

This clinical trial studies the following conditions: Spondylolisthesis, Spinal Stenosis, Degenerative Disease.

What interventions are being tested in trial NCT05366140?

The interventions under investigation include: Prospective follow-up of patients who have received instrumented lumbar arthrodesis supplemented the Implanet Jazz System(TM) (OTHER).

Who is sponsoring clinical trial NCT05366140?

This trial is sponsored by Francis Farhadi, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05366140 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spondylolisthesis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05366140's enrollment target sits among peer trials

300 3rd of 18 higher than 16 of 18 other Spondylolisthesis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spondylolisthesis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05366140, the US trial registry maintained by the National Library of Medicine. NCT05366140 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.